Hormone replacement therapy in BRCA mutation carriers and risk of ovarian, endometrial, and breast cancer: a systematic review

PURPOSE: BRCA mutation carriers have an increased risk of developing breast or ovarian cancer. Risk-reducing bilateral salpingo-oophorectomy (RRBSO) is associated with a decrease in risk for tubal and ovarian cancer. Hormone replacement therapy (HRT) may increase breast, ovarian, and endometrial can...

Descripción completa

Detalles Bibliográficos
Autores principales: Huber, D., Seitz, S., Kast, K., Emons, G., Ortmann, O.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Review – Clinical Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8164576/
https://www.ncbi.nlm.nih.gov/pubmed/33885953
http://dx.doi.org/10.1007/s00432-021-03629-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8164576/
https://www.ncbi.nlm.nih.gov/pubmed/33885953
http://dx.doi.org/10.1007/s00432-021-03629-z

Ejemplares similares